ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 708376 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 708376; 2) Community: the network communities that were significantly associated with the response to NSC 708376; 3) Molecule: the relationships between components within communities and NSC 708376; 4) MDR: the compounds that were significantly associated with the NSC 708376.

NSC Compound Enrichment Correlation
NSC 708423 Null 0.0414190425892865 -0.19391539
NSC 720299 Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate-~ 3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclo pentane 0.0414190425892865 0.025374318
NSC 722854 1,4-di-N-oxide-2-phenylcarbonyl-3-trifluoromethylquinoxaline 0.0414190425892865 0.078927718
NSC 709440 Null 0.0414190425892871 0.19801018
NSC 709483 Null 0.0414190425892871 -0.26582517
NSC 740 Methotrexate 0.0414190425892871 -0.24390552
NSC 747461 Null 0.0414190425892871 0.18737675
NSC 749297 N'-{2-[2-(4-Methoxy-phenyl)-vinyl]quinazolin-4-yl}-N,N-dimethyl-propane-1,3-diamine hydrochloride 0.0414190425892871 -0.15851176
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0414190425892871 -0.021660862
NSC 163062 TRIPTOLIDE 0.0421163101172308 -0.25920818
Total:63  Current:54    [First] [Prev] [Next] [Last]